Clinical Trials
3 trialsNCT01552434 2026-05-15
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT02654340 2023-02-10
TuScCom
CENTOGENE GmbH Rostock
Terminated
NCT00790400 2017-02-17
EXIST-2
Novartis
Phase 3 Completed